Updated from 4:39 p.m. ESTDrugmaker Allergan ( AGN - Get Report) said Wednesday its profit dropped in the fourth quarter and that it would cut 460 jobs. The Irvine, Calif., Botox maker said fourth-quarter profit fell to $150.6 million, or 50 cents per share, from $160.3 million, or 52 cents per share, in the fourth quarter of 2008. Revenue fell 3% to $1.06 billion from $1.09 billion. Eating into the company's bottom line this year were payments for licensing deals and a $13.2 million distribution settlement. Adjusted earnings were 76 cents per share. Analysts had expected earnings of 73 cents per share on $1.04 billion in revenue. According to The Associated Press, Allergan said that spend-wary patients who use cash-cow drug Botox are waiting longer between wrinkle treatments and that the drug's other uses -- which include alleviating excessive sweating and treating certain kinds of neck pain, eyelid spasms and crossed eyes -- are susceptible to the economic slowdown. Allergan also said it would cut 460 jobs, focusing primarily on U.S. urology sales and marketing employees and marketing staff in the U.S. and Europe. Those restructuring measures will smack the company with pretax charges of between $110 million and $117 million. Allergan's net annual income for 2008 was $578.6 million, or $1.89 per share, on $4.34 billion in revenue. Allergan shares, which closed up 1.2% to $40.28 in the regular session Wednesday, were rising 0.5% in extended trading. Among the company's direct competitors, Alcon ( ACL) ended the day down 0.6% to $84.47, and Elan ( ELN) rose 2.7% to $8.05.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
More from Stocks
Stocks End Slightly Higher in Cautious Trading Ahead of Federal Reserve Meeting
Stocks end moderately ahead as investors are adopting a cautious stance heading into this week's Federal Reserve meeting.
Medical Marijuana Card: Everything You Need to Know
Trying to get a medical marijuana card? Here's what you need to know.
Apple's Reported 2020 iPhone Plans Are a Positive for Broadcom
According to a new report from a respected analyst, Apple plans to launch 5.4-inch and 6.7-inch flagship iPhones next year, each of which will feature quite a few Broadcom 5G RF chips.